These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

532 related articles for article (PubMed ID: 30305310)

  • 1. Bile Acid G Protein-Coupled Membrane Receptor TGR5 Modulates Aquaporin 2-Mediated Water Homeostasis.
    Li S; Qiu M; Kong Y; Zhao X; Choi HJ; Reich M; Bunkelman BH; Liu Q; Hu S; Han M; Xie H; Rosenberg AZ; Keitel V; Kwon TH; Levi M; Li C; Wang W
    J Am Soc Nephrol; 2018 Nov; 29(11):2658-2670. PubMed ID: 30305310
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Activation of TGR5 restores AQP2 expression via the HIF pathway in renal ischemia-reperfusion injury.
    Han M; Li S; Xie H; Liu Q; Wang A; Hu S; Zhao X; Kong Y; Wang W; Li C
    Am J Physiol Renal Physiol; 2021 Mar; 320(3):F308-F321. PubMed ID: 33427060
    [TBL] [Abstract][Full Text] [Related]  

  • 3. FXR/TGR5 Dual Agonist Prevents Progression of Nephropathy in Diabetes and Obesity.
    Wang XX; Wang D; Luo Y; Myakala K; Dobrinskikh E; Rosenberg AZ; Levi J; Kopp JB; Field A; Hill A; Lucia S; Qiu L; Jiang T; Peng Y; Orlicky D; Garcia G; Herman-Edelstein M; D'Agati V; Henriksen K; Adorini L; Pruzanski M; Xie C; Krausz KW; Gonzalez FJ; Ranjit S; Dvornikov A; Gratton E; Levi M
    J Am Soc Nephrol; 2018 Jan; 29(1):118-137. PubMed ID: 29089371
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Disruption of prostaglandin E2 receptor EP4 impairs urinary concentration via decreasing aquaporin 2 in renal collecting ducts.
    Gao M; Cao R; Du S; Jia X; Zheng S; Huang S; Han Q; Liu J; Zhang X; Miao Y; Kang J; Gustafsson JÅ; Guan Y
    Proc Natl Acad Sci U S A; 2015 Jul; 112(27):8397-402. PubMed ID: 26100911
    [TBL] [Abstract][Full Text] [Related]  

  • 5. P2Y12 Receptor Localizes in the Renal Collecting Duct and Its Blockade Augments Arginine Vasopressin Action and Alleviates Nephrogenic Diabetes Insipidus.
    Zhang Y; Peti-Peterdi J; Müller CE; Carlson NG; Baqi Y; Strasburg DL; Heiney KM; Villanueva K; Kohan DE; Kishore BK
    J Am Soc Nephrol; 2015 Dec; 26(12):2978-87. PubMed ID: 25855780
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 4-PBA improves lithium-induced nephrogenic diabetes insipidus by attenuating ER stress.
    Zheng P; Lin Y; Wang F; Luo R; Zhang T; Hu S; Feng P; Liang X; Li C; Wang W
    Am J Physiol Renal Physiol; 2016 Oct; 311(4):F763-F776. PubMed ID: 27385737
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tamoxifen attenuates development of lithium-induced nephrogenic diabetes insipidus in rats.
    Tingskov SJ; Hu S; Frøkiær J; Kwon TH; Wang W; Nørregaard R
    Am J Physiol Renal Physiol; 2018 May; 314(5):F1020-F1025. PubMed ID: 29357422
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Aliskiren increases aquaporin-2 expression and attenuates lithium-induced nephrogenic diabetes insipidus.
    Lin Y; Zhang T; Feng P; Qiu M; Liu Q; Li S; Zheng P; Kong Y; Levi M; Li C; Wang W
    Am J Physiol Renal Physiol; 2017 Oct; 313(4):F914-F925. PubMed ID: 28228402
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Farnesoid X receptor induces Takeda G-protein receptor 5 cross-talk to regulate bile acid synthesis and hepatic metabolism.
    Pathak P; Liu H; Boehme S; Xie C; Krausz KW; Gonzalez F; Chiang JYL
    J Biol Chem; 2017 Jun; 292(26):11055-11069. PubMed ID: 28478385
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bile acid signaling in renal water regulation.
    Li S; Li C; Wang W
    Am J Physiol Renal Physiol; 2019 Jul; 317(1):F73-F76. PubMed ID: 31091123
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A dual agonist of farnesoid X receptor (FXR) and the G protein-coupled receptor TGR5, INT-767, reverses age-related kidney disease in mice.
    Wang XX; Luo Y; Wang D; Adorini L; Pruzanski M; Dobrinskikh E; Levi M
    J Biol Chem; 2017 Jul; 292(29):12018-12024. PubMed ID: 28596381
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development of lithium-induced nephrogenic diabetes insipidus is dissociated from adenylyl cyclase activity.
    Li Y; Shaw S; Kamsteeg EJ; Vandewalle A; Deen PM
    J Am Soc Nephrol; 2006 Apr; 17(4):1063-72. PubMed ID: 16495377
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fluconazole Increases Osmotic Water Transport in Renal Collecting Duct through Effects on Aquaporin-2 Trafficking.
    Vukićević T; Hinze C; Baltzer S; Himmerkus N; Quintanova C; Zühlke K; Compton F; Ahlborn R; Dema A; Eichhorst J; Wiesner B; Bleich M; Schmidt-Ott KM; Klussmann E
    J Am Soc Nephrol; 2019 May; 30(5):795-810. PubMed ID: 30988011
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combination of secretin and fluvastatin ameliorates the polyuria associated with X-linked nephrogenic diabetes insipidus in mice.
    Procino G; Milano S; Carmosino M; Barbieri C; Nicoletti MC; Li JH; Wess J; Svelto M
    Kidney Int; 2014 Jul; 86(1):127-38. PubMed ID: 24522493
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Farnesoid X receptor (FXR) gene deficiency impairs urine concentration in mice.
    Zhang X; Huang S; Gao M; Liu J; Jia X; Han Q; Zheng S; Miao Y; Li S; Weng H; Xia X; Du S; Wu W; Gustafsson JÅ; Guan Y
    Proc Natl Acad Sci U S A; 2014 Feb; 111(6):2277-82. PubMed ID: 24464484
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Liver X receptor β increases aquaporin 2 protein level via a posttranscriptional mechanism in renal collecting ducts.
    Su W; Huang SZ; Gao M; Kong XM; Gustafsson JÅ; Xu SJ; Wang B; Zheng F; Chen LH; Wang NP; Guan YF; Zhang XY
    Am J Physiol Renal Physiol; 2017 Apr; 312(4):F619-F628. PubMed ID: 28052875
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regulation of aquaporin-2 trafficking.
    Nedvetsky PI; Tamma G; Beulshausen S; Valenti G; Rosenthal W; Klussmann E
    Handb Exp Pharmacol; 2009; (190):133-57. PubMed ID: 19096775
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Integrin-linked kinase regulates tubular aquaporin-2 content and intracellular location: a link between the extracellular matrix and water reabsorption.
    Cano-Peñalver JL; Griera M; Serrano I; Rodríguez-Puyol D; Dedhar S; de Frutos S; Rodríguez-Puyol M
    FASEB J; 2014 Aug; 28(8):3645-59. PubMed ID: 24784577
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential effects of FXR or TGR5 activation in cholangiocarcinoma progression.
    Erice O; Labiano I; Arbelaiz A; Santos-Laso A; Munoz-Garrido P; Jimenez-Agüero R; Olaizola P; Caro-Maldonado A; Martín-Martín N; Carracedo A; Lozano E; Marin JJ; O'Rourke CJ; Andersen JB; Llop J; Gómez-Vallejo V; Padro D; Martin A; Marzioni M; Adorini L; Trauner M; Bujanda L; Perugorria MJ; Banales JM
    Biochim Biophys Acta Mol Basis Dis; 2018 Apr; 1864(4 Pt B):1335-1344. PubMed ID: 28916388
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genetic deletion of the nuclear factor of activated T cells 5 in collecting duct principal cells causes nephrogenic diabetes insipidus.
    Petrillo F; Chernyakov D; Esteva-Font C; Poulsen SB; Edemir B; Fenton RA
    FASEB J; 2022 Nov; 36(11):e22583. PubMed ID: 36197017
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.